Related Articles
Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells
Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy
Recombinant adenovirus of SEA and CD80 genes driven by MMRE and mouse TERT promoter induce effective antitumor immune responses against different types of tumor cells in vitro and in vivo
GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER
Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy